Baupost Group
Streaks
New in this book this quarter: CME, AXTA, PS.
Over time
Filings
- Q2 2026 filed Aug 13, 26 $5.4B · 23 positions · 3 new · 2 exited full · Concentrated 3 new · 2 exited
- Q1 2026 filed May 14, 26 $5.1B · 22 positions · 6 new · 6 exited full · Concentrated 6 new · 6 exited
- Q4 2025 filed Feb 13, 26 $5.3B · 22 positions · 3 new · 1 exited full · Concentrated 3 new · 1 exited
- Q3 2025 filed Nov 13, 25 $4.8B · 20 positions · 3 new · 5 exited full · Concentrated 3 new · 5 exited
- Q2 2025 filed Aug 13, 25 $4.1B · 22 positions · 3 new · 3 exited full · Concentrated 3 new · 3 exited
- Q1 2025 filed May 14, 25 $3.5B · 22 positions · 4 new · 3 exited full · Concentrated 4 new · 3 exited
- Q4 2024 filed Feb 13, 25 $3.4B · 21 positions · 4 new · 3 exited full · Concentrated 4 new · 3 exited
- Q3 2024 filed Nov 13, 24 $3.5B · 20 positions · 5 new · 8 exited full · Very concentrated 5 new · 8 exited
- Q2 2024 filed Aug 13, 24 $3.5B · 23 positions · 5 new · 3 exited full · Concentrated 5 new · 3 exited
- Q1 2024 filed May 14, 24 $3.5B · 21 positions · 5 new · 7 exited full · Very concentrated 5 new · 7 exited
- Q4 2023 filed Feb 13, 24 $4.6B · 23 positions · 0 new · 8 exited full · Concentrated 0 new · 8 exited
- Q3 2023 filed Nov 13, 23 $5.1B · 31 positions · 8 new · 5 exited full · Concentrated 8 new · 5 exited
- Q2 2023 filed Aug 11, 23 $5.5B · 28 positions · 5 new · 7 exited full · Concentrated 5 new · 7 exited
- Q1 2023 filed May 12, 23 $5.8B · 30 positions · 3 new · 5 exited full · Concentrated 3 new · 5 exited
- Q4 2022 filed Feb 13, 23 $6.1B · 32 positions · 3 new · 16 exited full · Concentrated 3 new · 16 exited
- Q3 2022 filed Nov 14, 22 $5.8B · 45 positions · 3 new · 9 exited full · Concentrated 3 new · 9 exited
- Q2 2022 filed Aug 12, 22 $6.7B · 51 positions · 3 new · 6 exited full · Concentrated 3 new · 6 exited
- Q1 2022 filed May 13, 22 $9.3B · 54 positions · 3 new · 2 exited full · Concentrated 3 new · 2 exited
- Q4 2021 filed Feb 11, 22 $10.1B · 53 positions · 7 new · 10 exited full · Concentrated 7 new · 10 exited
- Q3 2021 filed Nov 12, 21 $10.9B · 56 positions · 7 new · 9 exited full · Concentrated 7 new · 9 exited
- Q2 2021 filed Aug 13, 21 $12.3B · 58 positions · 7 new · 7 exited full · Concentrated 7 new · 7 exited
- Q1 2021 filed May 14, 21 $12.5B · 58 positions · 27 new · 13 exited full · Concentrated 27 new · 13 exited
- Q4 2020 filed Feb 12, 21 $10.8B · 44 positions · 15 new · 7 exited full · Concentrated 15 new · 7 exited
- Q3 2020 filed Nov 13, 20 $9.2B · 36 positions · 11 new · 5 exited full · Concentrated 11 new · 5 exited
- Q2 2020 filed Aug 13, 20 $8.0B · 30 positions · 4 new · 6 exited full · Concentrated 4 new · 6 exited
- Q1 2020 filed May 14, 20 $6.7B · 32 positions · 8 new · 5 exited full · Concentrated 8 new · 5 exited
- Q4 2019 filed Feb 13, 20 $8.6B · 29 positions · 4 new · 5 exited full · Concentrated 4 new · 5 exited
- Q3 2019 filed Nov 13, 19 $8.5B · 30 positions · 3 new · 3 exited full · Concentrated 3 new · 3 exited
- Q2 2019 filed Aug 13, 19 $10.7B · 30 positions · 1 new · 4 exited full · Concentrated 1 new · 4 exited
- Q1 2019 filed May 15, 19 $11.5B · 33 positions · 8 new · 10 exited full · Concentrated 8 new · 10 exited
- Q4 2018 filed Feb 13, 19 $11.1B · 35 positions · 6 new · 7 exited full · Concentrated 6 new · 7 exited
- Q3 2018 filed Nov 15, 18 $12.7B · 36 positions · 6 new · 1 exited full · Concentrated 6 new · 1 exited
- Q2 2018 filed Aug 13, 18 $11.1B · 31 positions · 6 new · 6 exited full · Concentrated 6 new · 6 exited
- Q1 2018 filed May 14, 18 $10.3B · 31 positions · 1 new · 3 exited full · Concentrated 1 new · 3 exited
- Q4 2017 filed Feb 13, 18 $10.1B · 33 positions · 2 new · 5 exited full · Concentrated 2 new · 5 exited
- Q3 2017 filed Nov 13, 17 $8.0B · 36 positions · 5 new · 8 exited full · Concentrated 5 new · 8 exited
- Q2 2017 filed Aug 11, 17 $8.7B · 39 positions · 4 new · 6 exited full · Concentrated 4 new · 6 exited
- Q1 2017 filed May 25, 17 $8.4B · 41 positions · 5 new · 6 exited full · Concentrated 5 new · 6 exited
- Q4 2016 filed Feb 14, 17 $7.6B · 42 positions · 12 new · 13 exited full · Concentrated 12 new · 13 exited
- Q3 2016 filed Nov 14, 16 $7.0B · 43 positions · 12 new · 7 exited full · Concentrated 12 new · 7 exited
- Q2 2016 filed Aug 12, 16 $7.3B · 38 positions · 10 new · 5 exited full · Concentrated 10 new · 5 exited
- Q1 2016 filed May 13, 16 $6.9B · 33 positions · 6 new · 7 exited full · Concentrated 6 new · 7 exited
- Q4 2015 filed Feb 12, 16 $5.5B · 34 positions · 1 new · 7 exited full · Concentrated 1 new · 7 exited
- Q3 2015 filed Nov 13, 15 $6.0B · 40 positions · 9 new · 0 exited full · Concentrated 9 new · 0 exited
- Q2 2015 filed Aug 13, 15 $6.0B · 31 positions · 5 new · 1 exited full · Concentrated 5 new · 1 exited
- Q1 2015 filed May 14, 15 $5.9B · 27 positions · 2 new · 1 exited full · Concentrated 2 new · 1 exited
- Q4 2014 filed Nov 14, 14 $5.1B · 26 positions · 4 new · 4 exited full · Very concentrated 4 new · 4 exited
- Q3 2014 filed Nov 14, 14 $5.7B · 26 positions · 3 new · 1 exited full · Very concentrated 3 new · 1 exited
- Q2 2014 filed Aug 14, 14 $6.1B · 24 positions · 5 new · 1 exited full · Very concentrated 5 new · 1 exited
- Q1 2014 filed May 14, 14 $4.1B · 20 positions · 4 new · 3 exited full · Very concentrated 4 new · 3 exited
- Q4 2013 filed Feb 13, 14 $3.5B · 19 positions · 3 new · 3 exited full · Very concentrated 3 new · 3 exited
- Q3 2013 filed Nov 13, 13 $3.5B · 19 positions · 1 new · 4 exited full · Very concentrated 1 new · 4 exited
- Q2 2013 filed Aug 13, 13 $3.9B · 22 positions · 0 new · 0 exited full · Very concentrated 0 new · 0 exited






